As of Sep 28
| +0.17 / +0.31%|
The 4 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 66.50, with a high estimate of 86.00 and a low estimate of 60.00. The median estimate represents a +22.33% increase from the last price of 54.36.
The current consensus among 6 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.